MUFG Securities EMEA plc

Broker-Dealer

Position in LLY — ELI LILLY & Co

CIK 1597694 LONDON, X0

Position in LLY

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$29,880,567

-$5,106,718 QoQ

Shares Held

32,487

-0.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MUFG Securities EMEA plc holds $423,932,325 across 10 Drug Manufacturers - General names. LLY ranks #4 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,980	$170,394,135
2	ABBV	AbbVie Inc.	432,445	$94,052,463
3	GILD	Gilead Sciences, Inc.	521,862	$72,731,906
4	LLY	ELI LILLY & Co This page	32,487	$29,880,567
5	JNJ	Johnson & Johnson	98,798	$24,150,183
6	MRK	Merck & Co., Inc.	101,752	$12,239,748
7	AMGN	Amgen Inc	22,085	$7,770,607
8	PFE	Pfizer Inc	233,159	$6,547,104

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$29,880,567	32,487	-0.2%	Shares	Defined	2026-05-11
2025-12-31	$34,987,285	32,556	+39.0%	Shares	Defined	2026-02-10
2025-09-30	$17,867,171	23,417	+907.6%	Shares	Sole	2025-11-14
2025-06-30	$1,811,627	2,324	-82.1%	Shares	Sole	2025-10-07
2024-12-31	$10,036,000	13,000	-55.2%	Shares	Sole	2025-02-12
2024-09-30	$25,692,260	29,000	+55669.2%	Shares	Sole	2024-11-13
2024-06-30	$47,079	52	0.0%	Shares	Sole	2024-07-31
2024-03-31	$40,453	52	-99.9%	Shares	Sole	2024-05-15
2021-09-30	$8,779,900	38,000	+90.0%	Shares	Sole	2021-11-12
2020-12-31	$3,376,800	20,000	-79.9%	Shares	Sole	2021-02-11
2020-09-30	$14,742,792	99,600	+99.2%	Shares	Sole	2020-11-13
2020-06-30	$8,209,000	50,000	-80.6%	Shares	Sole	2020-08-13
2020-03-31	$35,795,308	258,040	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.